Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 120701000001118 | COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech) (Pfizer Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 120721000001113 | COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech) (Pfizer Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 134651000001116 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 134661000001118 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1676781000001114 | Courageous 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Secretary of State for Health) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1676791000001111 | Courageous 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Secretary of State for Health) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1697791000001116 | COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech) (Pfizer-BioNTech) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1697801000001117 | COVID-19 mRNA Vaccine BNT162b2 30micrograms/0.3ml dose concentrate for suspension for injection multidose vials (Pfizer-BioNTech) (Pfizer-BioNTech) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1926001000001115 | Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1926021000001110 | Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2011021000001116 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2011041000001114 | COVID-19 mRNA Vaccine Pfizer-BioNTech BNT162b2 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has dispensed dose form | Conventional release dispersion for injection | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has specific active ingredient | Tozinameran | false | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Is a | Comirnaty | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator | EMA (European Medicines Agency) monitoring | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has specific active ingredient | Tozinameran | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has dispensed dose form | Dispersion for injection | false | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction clinical trial | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Is a | Actual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Is a | Generic Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has dispensed dose form | Conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | VMP prescribing status (attribute) | Never valid to prescribe as a VMP | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 6 dose | Has AMP | True | Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Inferred relationship | Existential restriction modifier | |
| Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) 1170 dose 195 x 6 dose vials | Has AMP | True | Comirnaty COVID-19 mRNA Vaccine 30micrograms/0.3ml dose concentrate for dispersion for injection multidose vials (Pfizer Ltd) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR